|
WDFY3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.812100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.619800E-02 |
| Normal-vs-Stage2 |
7.083800E-01 |
| Normal-vs-Stage3 |
5.581300E-03 |
| Normal-vs-Stage4 |
2.665900E-02 |
| Stage1-vs-Stage2 |
1.926620E-01 |
| Stage1-vs-Stage3 |
8.681600E-02 |
| Stage1-vs-Stage4 |
4.072200E-01 |
| Stage2-vs-Stage3 |
1.957640E-02 |
| Stage2-vs-Stage4 |
1.087750E-01 |
| Stage3-vs-Stage4 |
7.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023410E-01 |
| Normal-vs-AfricanAmerican |
1.279400E-01 |
| Normal-vs-Asian |
2.327400E-01 |
| Caucasian-vs-AfricanAmerican |
7.451200E-01 |
| Caucasian-vs-Asian |
3.866400E-01 |
| AfricanAmerican-vs-Asian |
4.575600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.489900E-02 |
| Normal-vs-Female |
3.294800E-01 |
| Male-vs-Female |
6.066600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.152550E-01 |
| Normal-vs-Extreme_Weight |
2.713800E-02 |
| Normal-vs-Obese |
2.528400E-01 |
| Normal-vs-Extreme_Obese |
9.186800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.854800E-01 |
| Normal_Weight-vs-Obese |
6.086600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.532000E-01 |
| Extreme_Weight-vs-Obese |
4.325400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.578200E-01 |
| Obese-vs-Extreme_Obese |
6.455200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.516600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.944600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.335100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.736500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.180400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.175800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.400400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.478230E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.550750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.395200E-01 |
| Normal-VS-Type2 PRCC |
2.600000E-03 |
| Normal-VS-KIRP CIMP |
1.970810E-04 |
| Normal-VS-Unclassified PRCC |
4.929600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.095600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.111900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.334400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.929620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.183760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.763800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.076110E-02 |
| Normal-vs-N1 |
2.419100E-03 |
| Normal-vs-N2 |
7.944200E-02 |
| N0-vs-N1 |
4.586000E-01 |
| N0-vs-N2 |
5.900200E-01 |
| N1-vs-N2 |
8.758400E-01 |
|
|
